218 related articles for article (PubMed ID: 30723507)
1. Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells.
Ceccarelli S; Megiorni F; Bellavia D; Marchese C; Screpanti I; Checquolo S
Stem Cells Int; 2019; 2019():6264931. PubMed ID: 30723507
[TBL] [Abstract][Full Text] [Related]
2. Correlation of
Kim MJ; Kim AR; Jeong JY; Kim KI; Kim TH; Lee C; Chung K; Ko YH; An HJ
J Cancer; 2017; 8(16):3331-3342. PubMed ID: 29158806
[No Abstract] [Full Text] [Related]
3. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
5. The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies.
Xiu M; Wang Y; Li B; Wang X; Xiao F; Chen S; Zhang L; Zhou B; Hua F
Front Mol Biosci; 2021; 8():694141. PubMed ID: 34195229
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling.
Fang Y; Xiao X; Wang J; Dasari S; Pepin D; Nephew KP; Zamarin D; Mitra AK
NPJ Precis Oncol; 2024 Jan; 8(1):7. PubMed ID: 38191909
[TBL] [Abstract][Full Text] [Related]
7. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells.
Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ
Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830
[TBL] [Abstract][Full Text] [Related]
8. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract][Full Text] [Related]
9. Targeting ovarian cancer stem cells: a new way out.
Ma H; Tian T; Cui Z
Stem Cell Res Ther; 2023 Feb; 14(1):28. PubMed ID: 36788591
[TBL] [Abstract][Full Text] [Related]
10. Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Roy L; Cowden Dahl KD
Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30042330
[TBL] [Abstract][Full Text] [Related]
11. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
12. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.
Ma Y; Li M; Si J; Xiong Y; Lu F; Zhang J; Zhang L; Zhang P; Yang Y
Int J Oncol; 2016 Jun; 48(6):2349-58. PubMed ID: 27035162
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
14. NOTCH signalling in ovarian cancer angiogenesis.
Perez-Fidalgo JA; Ortega B; Simon S; Samartzis EP; Boussios S
Ann Transl Med; 2020 Dec; 8(24):1705. PubMed ID: 33490217
[TBL] [Abstract][Full Text] [Related]
15. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
[TBL] [Abstract][Full Text] [Related]
16. A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.
Nwani NG; Condello S; Wang Y; Swetzig WM; Barber E; Hurley T; Matei D
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30965686
[TBL] [Abstract][Full Text] [Related]
17. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
18. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
[TBL] [Abstract][Full Text] [Related]
19. LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
Liu C; Liu L; Chen X; Cheng J; Zhang H; Zhang C; Shan J; Shen J; Qian C
Cancer Res; 2018 Feb; 78(4):938-949. PubMed ID: 29259010
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting.
Zong X; Nephew KP
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
